🇨🇦 Praxbind in Canada

Praxbind (IDARUCIZUMAB) regulatory status in Canada.

Marketing authorisation

Praxbind in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Canada

Frequently asked questions

Is Praxbind approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Praxbind in Canada?

Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.